Valuation: Adocia

Market Cap 81.51M 92.84M 75.03M 69.91M 132M 8.83B 135M 902M 350M 4.33B 349M 341M 15.08B P/E 2026 *
16.8x
P/E 2027 * -10.3x
Enterprise Value 32.75M 37.3M 30.14M 28.09M 52.97M 3.55B 54.05M 363M 140M 1.74B 140M 137M 6.06B EV / Sales 2026 *
0.85x
EV / Sales 2027 * -0.68x
Free-Float
89.7%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 55 11/05/2023
Director of Finance/CFO - 23/09/2024
Chief Tech/Sci/R&D Officer - 01/12/2014
Director TitleAgeSince
Director/Board Member 55 19/04/2013
Chairman 80 24/02/2012
Director/Board Member 58 18/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 92.84M
+4.49%+6.09%+77.30%+137.38% 56.21B
+0.55%+8.49%+77.09%+100.93% 55.38B
+4.30%+8.84%-9.52%-9.15% 23.75B
+3.86%+5.86%+12.57%+432.96% 23.19B
+3.64%+10.54%+39.81%-4.50% 18.14B
+4.07%+8.66%+44.29%-27.88% 16.84B
+1.49%+17.24%+174.91%+344.55% 15.86B
+3.64%+5.22%+26.43%+192.79% 13.56B
+7.20%+10.70%+42.91% - 12.97B
Average +3.34%+6.94%+53.98%+145.88% 26.21B
Weighted average by Cap. +3.30%+6.60%+58.65%+137.54%

Financials

2026 *2027 *
Net sales 38.39M 43.72M 35.33M 32.92M 62.09M 4.16B 63.36M 425M 165M 2.04B 164M 161M 7.1B 14.75M 16.8M 13.58M 12.65M 23.86M 1.6B 24.35M 163M 63.27M 784M 63.08M 61.72M 2.73B
Net income 3.98M 4.53M 3.66M 3.41M 6.43M 431M 6.56M 44.02M 17.06M 211M 17M 16.64M 736M -8.01M -9.12M -7.37M -6.87M -12.95M -867M -13.22M -88.66M -34.35M -426M -34.25M -33.51M -1.48B
Net Debt -48.77M -55.54M -44.89M -41.83M -78.88M -5.28B -80.48M -540M -209M -2.59B -209M -204M -9.02B -91.47M -104M -84.2M -78.46M -148M -9.9B -151M -1.01B -392M -4.86B -391M -383M -16.92B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-